AR100744A1 - ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES - Google Patents
ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USESInfo
- Publication number
- AR100744A1 AR100744A1 ARP150101787A ARP150101787A AR100744A1 AR 100744 A1 AR100744 A1 AR 100744A1 AR P150101787 A ARP150101787 A AR P150101787A AR P150101787 A ARP150101787 A AR P150101787A AR 100744 A1 AR100744 A1 AR 100744A1
- Authority
- AR
- Argentina
- Prior art keywords
- gitr
- necrosis factor
- tumor necrosis
- glucocorticoids
- antibodies
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Anticuerpos, o porciones de fijación al antígeno de estos, que se fijan al receptor de TNF (factor de necrosis tumoral) inducible por glucocorticoides (GITR). También, usos de estas proteínas en aplicaciones terapéuticas, tales como el tratamiento del cáncer. Además, células que producen los anticuerpos, polinucleótidos que codifican la región variable de la cadena pesada y/o liviana y vectores que comprenden los polinucleótidos que codifican la región variable de la cadena pesada y/o liviana de los anticuerpos. Molécula biespecífica, composición, kit, método.Antibodies, or antigen binding portions thereof, that bind to the glucocorticoid-inducible TNF (tumor necrosis factor) receptor (GITR). Also, uses of these proteins in therapeutic applications, such as cancer treatment. In addition, cells that produce the antibodies, polynucleotides encoding the heavy and / or light chain variable region and vectors comprising the polynucleotides that encode the heavy and / or light chain variable region of the antibodies. Bispecific molecule, composition, kit, method.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462008945P | 2014-06-06 | 2014-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR100744A1 true AR100744A1 (en) | 2016-10-26 |
Family
ID=58699856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150101787A AR100744A1 (en) | 2014-06-06 | 2015-06-04 | ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR100744A1 (en) |
MA (1) | MA39559A1 (en) |
-
2015
- 2015-06-03 MA MA39559A patent/MA39559A1/en unknown
- 2015-06-04 AR ARP150101787A patent/AR100744A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA39559A1 (en) | 2018-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY36154A (en) | ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES | |
EA201891121A1 (en) | ANTIBODIES TO THE GLUKORTIKOID-INDUCED RECEPTOR OF THE TUMOR NECROSIS FACTOR (GITR) AND THEIR APPLICATIONS | |
CL2020003028A1 (en) | Anti-cd33 antibodies, anti-cd33 / anti-cd3 bispecific antibodies and their uses. | |
AR111288A1 (en) | ANTI-PHF-TAU ANTIBODIES AND ITS USES | |
PH12017502129A1 (en) | Antibodies against ox40 and uses thereof | |
CO2018000882A2 (en) | Antibody constructs for flt3 and cd3 | |
CL2018000502A1 (en) | Bispecific antibodies for pd1 and tim3 useful as immunomodulators or in the treatment of cancer. | |
EA201790060A1 (en) | BISPECIFIC CD33- and CD3-BINDING PROTEINS | |
PE20210488A1 (en) | ANTIBODIES SPECIFIC TO GUCY2C AND ITS USES | |
CR20180065A (en) | BIESPECTIFIC ANTIBODY CONSTRUCTS THAT JOIN EGFRVIII AND CD3 | |
AR106365A1 (en) | BISPECIFIC MOLECULES OF ANTIGEN BINDING TO T-CELL ACTIVATORS | |
CR20170079A (en) | UNION AGENTS TO CD123 AND USES OF THESE | |
EA201891331A1 (en) | BIPARATOPE POLYPEPTIDES - ANTAGONISTS OF TRANSMISSION OF WNT SIGNAL IN TUMOR CELLS | |
CU24437B1 (en) | ANTI-GITR AGONIST ANTIBODIES AND COMPOSITIONS OF THE SAME | |
EA202191380A1 (en) | ANTIBODIES TO ALPHA-SYNUCLEINE AND THEIR APPLICATION | |
EA201492101A1 (en) | ANTIBODIES AGAINST FCRN | |
EA201792581A1 (en) | METHODS OF APPLICATION OF BISPECIFIC CD33- and CD3-BINDING PROTEINS | |
CL2016000438A1 (en) | Humanized antibodies that specifically bind to the colony stimulating factor 1 receptor (csf-1r); nucleic acids; expression vectors, host cells; production processes; pharmaceutical compositions; uses and methods of therapeutic treatment for the treatment of cancer and fibrotic disease | |
JOP20210085A1 (en) | Anti-TNF?-antibodies and functional fragments thereof | |
EA201690992A1 (en) | ANTIBODIES SPECIFIC TO FCRN | |
EA201891594A1 (en) | ANTIBODIES TO IL-17C | |
AR100744A1 (en) | ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES | |
EA202090533A2 (en) | ANTIBODIES TO OX40 AND THEIR APPLICATION | |
AR107834A1 (en) | ANTIBODIES THAT JOIN THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR), METHODS AND USES | |
EA202090841A2 (en) | MOLECULES BINDING WITH EGFR AND c-MET WITH TYPE III FIBRONECTIN DOMAINS |